PLx Pharma Secures $9,000,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=df053848-28c1-44da-bd08-3e0a8ae75a58 - Date
7/9/2013 - Company Name
PLx Pharma - Mailing Address
8285 El Rio Houston, TX 77054 - Company Description
PLx Pharma is a pharmaceutical company developing the next generation of non-steroidal anti-inflammatory agents (NSAIDs) that are safer on the gut. - Website
http://www.plxpharma.com - Transaction Type
Venture Equity - Transaction Amount
$9,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
